A study conducted at the University of Texas identified two antibodies, hu11E6 and hu1B7, that can prevent toxins associated ...

Not just IgG4 antibodies that become predominant in the many-jabbed, but also lesser studied IgG2, researchers find. NIH ...

Blood cancer patients who receive a type of anti-cancer therapy should continue to take the drug while having COVID-19 ...

Researchers at the University of Cologne and University Hospital Cologne have determined that the novel mRNA-based COVID-19 ...

Viruses like SARS-CoV-2 use sugar molecules to hide from the immune system, but scientists at Scripps Research have designed ...

New research findings provide solid evidence that annual COVID-19 vaccine booster doses continue to be advisable for certain immunocompromised people, researchers at McGill University say. The ...

New research from The University of Texas (UT) at Austin in the US could aid in improving whooping cough vaccines, to push ...

Although the bivalent COVID-19 vaccine conferred moderate protection against symptomatic disease, hybrid immunity provided the strongest protection.

New research findings provide evidence that annual COVID-19 vaccine booster doses continue to be advisable for certain ...

Early animal studies show that a single vaccine could protect the recipient from different variants of the coronaviruses that cause COVID-19, the flu and the common cold. In addition to creating ...

Vermont has the second lowest state fatality rate in the US (146.4 per 100K; Hawaii 112.8/100K). Mississippi (463.3/100K) and ...

Published in Vaccines, the study found that 15% of IMID patients contracted COVID-19 at least once during the year-long study, but that patients with higher levels of a specific antibody ...